Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 629-705-7 | CAS number: 1228186-15-9
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Data on toxicokinetics for N-benzyl-N-C16-18 (even numbered)-alkyl-N-methyl-C16-18 (even numbered)-alkyl-1-aminium chloride (BDHTMAC) are not available.
However, experimental data on toxicokinetic aspects exist for the structural analogue N-C16-C18 (even numbered) -alkyl-N,N-dimethyl- C16-C18 (even numbered)-alkyl-1-aminium chloride (DHTDMAC)
which allow basic considerations concerning toxicokinetic parameter like absorption.After dermal administration of the radiolabelled structural analogue to rabbits, most of the radioactivity remained at the site of application (88 ± 2.3%). Only traces of administered radioactivity were detected over a 72 h-period in urine (0.15 %), faeces (0.16 %), exhaled carbon dioxide (0.27 %), other skin (0.2%) and cage wash (0.3%) (Drotman R.B.(1977) Metabolism of cutaneously applied surfactants, Cutan.toxic., 3,95 -109).
In in-vitro-studies on human abdominal skin no absorption of the structural analogue was detected (no further information was given, Drotman, 1977).
These experimental findings on the strucutural analogue are supported by the physicochemical properties of N-benzyl-N-C16-18 (even numbered) -alkyl-N-methyl-C16-18 (even numbered)-alkyl-1-aminium chloride (BDHTMAC)
being poorly soluble in water and existing as a quaternary ammonium salt in an ionic state, uncharged molecules, however, are absorbed. Furthermore, the substance has a molecular weight of about 606 -659 g/mol (data from section1.1 identification), usually only substances with lower molecular weight are absorbed. Therefore, the dermal absorption and the concentration of the substance in the skin can be assumed to be very low.
With regard to potential inhalative exposure, due to the low vapour pressure of the dialkylquaternaries the potential for generating vapour and thus inhaling them is minimal. In the unlikely event that aerosols or particulates are inhaled, the pulmonary physiology and clearance dynamics would largely favour the oral absorption than the inhalation. Based on physico-chemical properties, a low inhalative bioavailability can be anticipated.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
